Welcome to our dedicated page for Radnet SEC filings (Ticker: RDNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The RadNet, Inc. (RDNT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as a NASDAQ-listed issuer. RadNet files reports and current updates with the U.S. Securities and Exchange Commission in connection with its operations as a national provider of freestanding, fixed-site diagnostic imaging services and as the parent of the DeepHealth digital health division.
Among the filings that investors commonly review are annual reports on Form 10-K and quarterly reports on Form 10-Q, which present information on RadNet’s Imaging Center and Digital Health reportable segments, revenue composition, imaging volumes, liquidity and capital structure. Current reports on Form 8-K are used to disclose specific material events, such as the release of quarterly financial results or the filing of a prospectus supplement under an automatic shelf registration statement. For example, RadNet has filed 8-Ks to furnish press releases detailing financial results for quarters ended June 30, 2025 and September 30, 2025, and to report the filing of a prospectus supplement registering shares of common stock for resale by selling stockholders.
Through this filings page, users can also monitor documents related to securities offerings, including prospectus supplements and associated legal opinions, as well as other disclosures that may affect the company’s capital markets activity. Forms related to insider transactions, such as Form 4, and proxy materials on executive compensation and governance are part of the broader SEC record and can be relevant for understanding management incentives and ownership changes.
Stock Titan enhances access to these filings by pairing real-time updates from the SEC’s EDGAR system with AI-powered summaries that explain key points in plain language. This can help readers interpret lengthy documents such as 10-K and 10-Q reports, understand the implications of 8-K announcements and quickly identify notable items in RadNet’s regulatory history. For anyone analyzing RDNT, the SEC filings page is a central source for official, time-stamped information on the company’s financial condition, segment performance and capital markets activity.
RadNet, Inc. (RDNT) filed a Form 144 reporting a proposed sale of 70,000 common shares with an aggregate market value of $4,452,000.00, to be sold approximately on 08/15/2025 on NASDAQ. The filing shows 74,036,993 shares outstanding, and the shares to be sold were acquired entirely through stock option exercises on multiple dates between 2016 and 2024. Each acquisition was paid by cash/check. The broker listed is Commonwealth Financial Network in Waltham, MA. The filer certifies there are no undisclosed material adverse facts and notes no securities were sold in the past three months.
RadNet insider sale recorded: The filing shows David Jeffrey Katz, Executive Vice President and Chief Legal Officer of RadNet, Inc. (RDNT), sold 17,000 shares of common stock on 08/13/2025 at a weighted average price of $68.31 per share. After the sale, Mr. Katz beneficially owned 86,774 shares, held directly. The filing notes the reported sale occurred in multiple transactions with prices ranging from $68.02 to $68.54. The form is signed by an attorney-in-fact on behalf of the reporting person.
RadNet reported higher second-quarter revenue and a return to quarterly profitability, but a six-month operating loss left common shareholders with a year-to-date deficit. Total service revenue for the three months ended June 30, 2025 was $498,230,000, up from $459,714,000 a year earlier, driven by growth across commercial and Medicare payors. The company recorded quarterly net income of $23,034,000, with net income attributable to RadNet common stockholders of $14,454,000 and diluted EPS of $0.19.
For the six months ended June 30, 2025 RadNet reported a consolidated net loss of $(6,703,000), and a net loss attributable to RadNet common stockholders of $(23,472,000) (diluted EPS $(0.32)). Operating cash flow improved to $161,829,000 for the six months. The company completed acquisitions, including See-Mode Technologies for approximately $28.7 million with contingent consideration of $8.8 million, and goodwill totaled $751,514,000 at June 30, 2025. Total long-term debt was $1,077,251,000.
RadNet, Inc. furnished a press release reporting its financial results for the second quarter ended June 30, 2025, with that press release included as Exhibit 99.1 to this Current Report. The filing identifies the disclosure under Item 2.02 (Results of Operations and Financial Condition) and also includes an interactive XBRL cover page as Exhibit 104. The company states the information is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act and will not be incorporated by reference into other filings except by specific reference.
Aside from the notice that Q2 2025 results were released, the report contains no financial figures, metrics, or commentary on performance. The report was executed on behalf of the registrant by Mark Stolper, Chief Financial Officer, and confirms the company’s common stock trades as RDNT on NASDAQ. Investors must consult Exhibit 99.1 for the detailed Q2 financial results.
RadNet EVP and Chief Science Officer Alma Gregory Sorensen reported a charitable donation of 5,600 shares of common stock on June 17, 2025. The transaction was executed at $0 as it was a gift (Transaction Code: G).
Following the transaction, Sorensen maintains direct beneficial ownership of 1,165,345 shares of RadNet common stock. The filing indicates that Sorensen serves in dual roles as both a Director and Executive Officer (EVP, Chief Science Officer) of the company.
Key Transaction Details:
- Transaction Type: Charitable Donation
- Direct Ownership Maintained
- No derivative securities were involved in this transaction
- Filing was signed by Jose Gamez as Attorney-in-Fact on June 18, 2025